Your browser doesn't support javascript.
loading
Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families.
Taylor, Nicholas J; Handorf, Elizabeth A; Mitra, Nandita; Avril, Marie-Françoise; Azizi, Esther; Bergman, Wilma; Bianchi-Scarrà, Giovanna; Bishop, D Timothy; Bressac-de Paillerets, Brigitte; Calista, Donato; Cannon-Albright, Lisa A; Cuellar, Francisco; Cust, Anne E; Demenais, Florence; Elder, David E; Friedman, Eitan; Gerdes, Anne-Marie; Ghiorzo, Paola; Goldstein, Alisa M; Grazziotin, Thais C; Hansson, Johan; Hayward, Nicholas K; Hocevar, Marko; Höiom, Veronica; Holland, Elizabeth A; Ingvar, Christian; Landi, Maria Teresa; Landman, Gilles; Larre-Borges, Alejandra; Leachman, Sancy A; Mann, Graham J; Nagore, Eduardo; Olsson, Håkan; Palmer, Jane; Peric, Barbara; Pjanova, Dace; Puig, Susana; Schmid, Helen; van der Stoep, Nienke; Tucker, Margaret A; Wadt, Karin A W; Whitaker, Linda; Yang, Xiaohong R; Newton Bishop, Julia A; Gruis, Nelleke A; Kanetsky, Peter A.
Afiliación
  • Taylor NJ; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
  • Handorf EA; Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Mitra N; Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Avril MF; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin et Université Paris Descartes, Paris, France.
  • Azizi E; Department of Dermatology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Bergman W; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Bianchi-Scarrà G; Department of Internal Medicine and Medical Specialties, University of Genoa and IRCCS AOU San Martino-IST Genoa, Italy.
  • Bishop DT; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
  • Bressac-de Paillerets B; Department of Biopathology and INSERM U1186, Gustave Roussy, Villejuif, France.
  • Calista D; Dermatology Unit, Maurizio Bufalini Hospital, Cesena, Italy.
  • Cannon-Albright LA; Division of Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Cuellar F; Melanoma Unit, Dermatology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain and CIBER de Enfermedades Raras, Barcelona, Spain.
  • Cust AE; Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
  • Demenais F; INSERM, UMR-946, Genetic Variation and Human Disease Unit, Université Paris Diderot, Paris, France.
  • Elder DE; Departments of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
  • Friedman E; The Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
  • Gerdes AM; Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark.
  • Ghiorzo P; Department of Internal Medicine and Medical Specialties, University of Genoa and IRCCS AOU San Martino-IST Genoa, Italy.
  • Goldstein AM; Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Grazziotin TC; Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre RS, Brazil.
  • Hansson J; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Hayward NK; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
  • Hocevar M; Institute of Oncology Ljubljana, Zaloska, Ljubljana, Slovenia.
  • Höiom V; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Holland EA; Centre for Cancer Research, Westmead Institute for Medical Research and Melanoma Institute Australia, University of Sydney, NSW, Australia.
  • Ingvar C; Department of Surgery, Lund University Hospital, Lund, Sweden.
  • Landi MT; Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Landman G; Department of Pathology, Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil.
  • Larre-Borges A; Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay.
  • Leachman SA; Oregon Health Sciences University School of Medicine, Department of Dermatology, Portland, Oregon, USA.
  • Mann GJ; Centre for Cancer Research, Westmead Institute for Medical Research and Melanoma Institute Australia, University of Sydney, NSW, Australia.
  • Nagore E; Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain.
  • Olsson H; Centre for Cancer Research, Westmead Institute for Medical Research and Melanoma Institute Australia, University of Sydney, NSW, Australia.
  • Palmer J; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
  • Peric B; Institute of Oncology Ljubljana, Zaloska, Ljubljana, Slovenia.
  • Pjanova D; Latvian Biomedical Research and Study Centre, Riga, Latvia.
  • Puig S; Melanoma Unit, Dermatology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain and CIBER de Enfermedades Raras, Barcelona, Spain.
  • Schmid H; Centre for Cancer Research, Westmead Institute for Medical Research and Melanoma Institute Australia, University of Sydney, NSW, Australia.
  • van der Stoep N; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Tucker MA; Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Wadt KAW; Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark.
  • Whitaker L; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
  • Yang XR; Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Newton Bishop JA; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
  • Gruis NA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Kanetsky PA; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. Electronic address: peter.kanetsky@moffitt.org.
J Invest Dermatol ; 136(5): 1066-1069, 2016 05.
Article en En | MEDLINE | ID: mdl-26827760
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Predisposición Genética a la Enfermedad / Inhibidor p18 de las Quinasas Dependientes de la Ciclina / Melanoma Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Invest Dermatol Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Predisposición Genética a la Enfermedad / Inhibidor p18 de las Quinasas Dependientes de la Ciclina / Melanoma Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Invest Dermatol Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos